Combination of bezafibrate and of resveratrol or resveratrol derivatives for the treatment and prevention of diseases involving a mitochondrial energy dysfunction
申请人:Institut National De La Santé Et De La Recherche Médicale (INSERM)
公开号:US10376484B2
公开(公告)日:2019-08-13
The present invention relates to the combined use of bezafibrate and of resveratrol or resveratrol derivatives for the treatment of diseases involving a mitochondrial energy dysfunction, and also to a pharmaceutical kit comprising both bezafibrate and resveratrol or resveratrol derivatives. The combination is more particularly used in the treatment of moderate defects of β-oxidation of long-chain fatty acids or of the respiratory chain of mitochondria.
本发明涉及联合使用贝扎贝特和白藜芦醇或白藜芦醇衍生物治疗涉及线粒体能量功能障碍的疾病,还涉及一种包含贝扎贝特和白藜芦醇或白藜芦醇衍生物的药物试剂盒。该组合药剂尤其可用于治疗长链脂肪酸β-氧化或线粒体呼吸链的中度缺陷。